Next generation rapid diagnostic tests for meningitis diagnosis
Related Experiment Video
Updated: Oct 8, 2026

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B
Published on: January 30, 2017
Alicia R Feagins1, Olivier Ronveaux2, Muhamed-Kheir Taha3
1National Center for Immunization and Respiratory Diseases, Center for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, GA 30333, United States.
Abstract:
Rapid diagnostic tests (RDTs) are increasingly recognized as valuable, transformative tools for the diagnosis of infectious diseases. Although there are a variety of meningitis RDTs currently available, certain product features restrict their use to specific levels of care and settings. For this reason, the development of meningitis RDTs for use at all levels of care, including those in low-resource settings, was included in the "Defeating Meningitis by 2030" roadmap. Here we address the limitations of available meningitis RDTs and present test options and specifications to consider when developing the next generation of meningitis RDTs.
More Related Videos
06:18Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
Published on: March 13, 2018
07:40Field Postmortem Rabies Rapid Immunochromatographic Diagnostic Test for Resource-Limited Settings with Further Molecular Applications
Published on: June 29, 2020
Related Concept Videos
Rapid Identification of Pathogens
Automated Microbial Diagnostics
Bacterial Meningitis
Viral Meningitis